Lead Engineer - Automation Systems, Cell Therapy Devens at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Cell Therapy, PharmaceuticalIndustries

Requirements

5+ years experience with DeltaV, PI, BAS, and OT Infrastructure
Expert understanding of S88, S95, and batch processing operations
Expert understanding engineering documentation such as P&IDs, network diagrams, process flow diagrams, and SOPs
Expert understanding of Validation Lifecycle Management, including the planning, creation, and execution of IQ’s, OQ’s, and PQ’s
Experience with QMS systems (Veeva, or similar) and GMP Quality Processes (Deviation Management, Change Controls, etc.)
Ability to troubleshoot network and control systems from the field element up through operator interfaces and databases
Experience with IT Ticketing Systems (ServiceNow or similar)
Excellent communication skills including oral, written, and formal presentations
Ability to clearly communicate technical information to a variety of audiences
Bachelor’s degree in engineering or its equivalent
5-7 years experience working with control systems (DeltaV, PI, BAS and PLC's) in the Pharmaceutical or Biotechnology sector
Preferred
Experience with Control System Networking Technologies and PC networking technologies
Experience working with SQL, Server, Oracle, or other relational databases
Experience with Validation Lifecycle Management Systems (Valgenesis, or similar)
Experience with Building Automation Systems
Experience with .Net scripting

Responsibilities

Technical lead and subject matter expert for the process automation systems and equipment
Lead substantial technical efforts, such as major system version upgrades or new process introductions
Integrate with cross-functional teams throughout the site to perform qualification and validation
Provide troubleshooting and guidance support to automation systems in support of Manufacturing as part of daily responsibilities and a 24/7 on-call rotation
Support audits as a front room representative
Maintain, configure, administer, and troubleshoot the DeltaV, PI, BAS, and integrated process equipment

Skills

DeltaV

BAS

Process Automation

System Administration

Troubleshooting

Validation

Qualification

Manufacturing Support

Audits

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free